NE

Neotis

1 known investors

neotis.com ↗

Neotis develops immunotherapies to counteract age-related tissue decline by directing the immune system, with an initial focus on fibrotic disease. The company combines expertise in immunology, senescence, and biomarker development.

Founders & leadership

CM

Cathal Meehan, PhDCEO

MS

Michael Saitakis, PhDCSO

Investors · 1

DA

DaphniParis · $540K – $6.5M